JillM(Cocchiola)WilliamsMD

Addiction

Director of the Division of Addiction Psychiatry, Robert Wood Johnson Medical School, Rutgers University. Professor of Psychiatry, Robert Wood Johnson Medical School, Rutgers University.

Join to view full profile

Dr. Williams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Williams' full profile

Already have an account?

Office
671 Hoes LN
D339
Piscataway, NJ 08854
Phone+1 732-235-4341

Fax+1 732-235-4277

Education & Training

Duke University HospitalResidency, Psychiatry, 1993 - 1997
Rutgers Robert Wood Johnson Medical SchoolClass of 1993

Certifications & Licensure

NJ State Medical License 1997 - 2025
NC State Medical License 1993 - 1999
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1 Start of enrollment: 2001 Aug 01
Terminated
Phase 4
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 Start of enrollment: 2003 Oct 01
Completed
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder Start of enrollment: 2006 Oct 01
Completed
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia Start of enrollment: 2009 Aug 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

2 citations
'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental heal...
Amanda L Baker, Kristen McCarter, Alyna Turner, Catherine Segan, David Castle
The Australian and New Zealand Journal of Psychiatry. 2024-03-01
Advancing Proficiencies for Health Professionals in the Treatment of Tobacco Use Among Marginalized Communities: Development of a Competency-Based Curriculum and Virtu...
Christine E Sheffer, Alina Shevorykin, Roberta Freitas-Lemos, Darian Vantucci, Ellen Carl
Substance Abuse. 2023-10-01
6 citations
Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
Anna Kline, Jill M Williams, Marc L Steinberg, Dina Mattern, Megan Chesin
Journal of Substance Use and Addiction Treatment. 2023-06-01

Lectures

Helping Smokers with Behavioral Health Comorbidity Requires a National Effort
National Institutes of Health (NIH), Bethesda, Maryland - 4/16/2013

Press Mentions

Minimum Age Raised to 21 for Tobacco, Nicotine PurchaseJanuary 31st, 2020
Tobacco Addiction, Treatment Need More Attention by CliniciansNovember 15th, 2016

Grant Support

R01-Williajm - Double-Blind Placebo-Controlled Trial Of Nicotine Nasal Spray As ANational Institute On Drug Abuse2009–2010
Nicotine Intake In Smokers With SchizophreniaNational Institute Of Mental Health2006–2009
Treatment Of Addiction To Nicotine In SchizophreniaNational Institute On Drug Abuse2006
Nicotine Dependence Treatment In Psychiatric ComorbidityNational Institute On Drug Abuse2001–2005